Margaret J. Thomason

5.6k total citations · 1 hit paper
32 papers, 3.6k citations indexed

About

Margaret J. Thomason is a scholar working on Infectious Diseases, Virology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Margaret J. Thomason has authored 32 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 11 papers in Virology and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Margaret J. Thomason's work include HIV/AIDS drug development and treatment (15 papers), HIV/AIDS Research and Interventions (14 papers) and HIV Research and Treatment (11 papers). Margaret J. Thomason is often cited by papers focused on HIV/AIDS drug development and treatment (15 papers), HIV/AIDS Research and Interventions (14 papers) and HIV Research and Treatment (11 papers). Margaret J. Thomason collaborates with scholars based in United Kingdom, Uganda and Zambia. Margaret J. Thomason's co-authors include G. A. Hitman, Helen M. Colhoun, D. J. Betteridge, H. A. W. Neil, Paul N. Durrington, Shona Livingstone, Valentine Charlton-Menys, Michael I. Mackness, John Fuller and Diana M. Gibb and has published in prestigious journals such as The Lancet, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Margaret J. Thomason

32 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

2004 2.7k citations Helen M. Colhoun, D. J. Betteridge et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Margaret J. Thomason United Kingdom	19	1.9k	1.8k	744	691	400	32	3.6k
S Tudy G Roup	8	2.5k 1.4×	1.1k 0.6×	762 1.0×	807 1.2×	316 0.8×	17	4.1k
Shona Livingstone United Kingdom	28	2.6k 1.4×	3.0k 1.7×	1.1k 1.5×	801 1.2×	693 1.7×	48	5.4k
Carl E. Orringer United States	24	2.4k 1.3×	1.2k 0.7×	1.0k 1.4×	787 1.1×	265 0.7×	55	3.7k
Matthew K. Ito United States	24	2.8k 1.5×	1.2k 0.7×	858 1.2×	912 1.3×	203 0.5×	71	3.9k
Erin A. Bohula United States	31	3.9k 2.1×	1.5k 0.9×	2.1k 2.8×	1.3k 1.9×	552 1.4×	97	6.3k
Núria Plana Spain	29	1.4k 0.7×	859 0.5×	689 0.9×	288 0.4×	353 0.9×	161	2.9k
Gabriele Riccardi Italy	14	3.0k 1.6×	1.6k 0.9×	1.5k 2.0×	972 1.4×	409 1.0×	20	4.5k
A Notarbartoló Italy	34	2.2k 1.2×	969 0.5×	999 1.3×	183 0.3×	823 2.1×	152	4.3k
Maria Carla Roncaglioni Italy	25	798 0.4×	813 0.5×	1.5k 2.0×	196 0.3×	397 1.0×	101	3.8k
Paul S. Jellinger United States	23	1.7k 0.9×	3.8k 2.1×	664 0.9×	342 0.5×	469 1.2×	38	5.4k

Countries citing papers authored by Margaret J. Thomason

Since Specialization

Citations

This map shows the geographic impact of Margaret J. Thomason's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margaret J. Thomason with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margaret J. Thomason more than expected).

Fields of papers citing papers by Margaret J. Thomason

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Margaret J. Thomason. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margaret J. Thomason. The network helps show where Margaret J. Thomason may publish in the future.

Co-authorship network of co-authors of Margaret J. Thomason

This figure shows the co-authorship network connecting the top 25 collaborators of Margaret J. Thomason. A scholar is included among the top collaborators of Margaret J. Thomason based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Margaret J. Thomason. Margaret J. Thomason is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Szubert, Alexander J., Andrew J. Prendergast, Moira Spyer, et al.. (2017). Virological response and resistance among HIV-infected children receiving long-term antiretroviral therapy without virological monitoring in Uganda and Zimbabwe: Observational analyses within the randomised ARROW trial. PLoS Medicine. 14(11). e1002432–e1002432. 19 indexed citations

Crook, Angela M., Anna Turkova, Victor Musiime, et al.. (2016). Tuberculosis incidence is high in HIV-infected African children but is reduced by co-trimoxazole and time on antiretroviral therapy. BMC Medicine. 14(1). 50–50. 34 indexed citations

Abongomera, George, Adrian Cook, Victor Musiime, et al.. (2016). Improved Adherence to Antiretroviral Therapy Observed Among HIV-Infected Children Whose Caregivers had Positive Beliefs in Medicine in Sub-Saharan Africa. AIDS and Behavior. 21(2). 441–449. 8 indexed citations

Prendergast, Andrew J., Mutsa Bwakura‐Dangarembizi, Peter Mugyenyi, et al.. (2016). Reduced bacterial skin infections in HIV-infected African children randomized to long-term cotrimoxazole prophylaxis. AIDS. 30(18). 2823–2829. 3 indexed citations

Mulenga, Veronica, Victor Musiime, Adeodata Kekitiinwa, et al.. (2015). Abacavir, zidovudine, or stavudine as paediatric tablets for African HIV-infected children (CHAPAS-3): an open-label, parallel-group, randomised controlled trial. The Lancet Infectious Diseases. 16(2). 169–179. 32 indexed citations

Arenas‐Pinto, Alejandro, JA Thompson, Godfrey Musoro, et al.. (2015). Peripheral neuropathy in HIV patients in sub-Saharan Africa failing first-line therapy and the response to second-line ART in the EARNEST trial. Journal of NeuroVirology. 22(1). 104–113. 27 indexed citations

Aitken, Susan C., Elton R. Kisanga, Chipepo Kankasa, et al.. (2013). Effect of 7 days of phenytoin on the pharmacokinetics of and the development of resistance to single-dose nevirapine for perinatal HIV prevention: a randomized pilot trial. Journal of Antimicrobial Chemotherapy. 68(11). 2609–2615. 2 indexed citations

Mulenga, Veronica, Chipepo Kankasa, Margaret J. Thomason, et al.. (2013). Is nevirapine dose-escalation appropriate in young, African, HIV-infected children?. AIDS. 27(13). 2111–2115. 14 indexed citations

Haberer, Jessica E., Adrian Cook, A Sarah Walker, et al.. (2011). Excellent Adherence to Antiretrovirals in HIV+ Zambian Children Is Compromised by Disrupted Routine, HIV Nondisclosure, and Paradoxical Income Effects. PLoS ONE. 6(4). e18505–e18505. 101 indexed citations

10.

Walker, A Sarah, Deborah Ford, Veronica Mulenga, et al.. (2008). Adherence to Both Cotrimoxazole and Placebo is Associated with Improved Survival Among HIV-Infected Zambian Children. AIDS and Behavior. 13(1). 33–41. 12 indexed citations

11.

L'homme, Rafaëlla FA, Fiona M Ewings, Veronica Mulenga, et al.. (2008). Nevirapine, stavudine and lamivudine pharmacokinetics in African children on paediatric fixed-dose combination tablets. AIDS. 22(5). 557–565. 47 indexed citations

12.

Colhoun, Helen M., D. J. Betteridge, Paul N. Durrington, et al.. (2005). Rapid emergence of effect of atorvastatin on cardiovascular outcomes in the Collaborative Atorvastatin Diabetes Study (CARDS). Diabetologia. 48(12). 2482–2485. 38 indexed citations

13.

Thomason, Margaret J., Jane Biddulph, C A Cull, & Rury R. Holman. (2005). Reporting of diabetes on death certificates using data from the UK Prospective Diabetes Study. Diabetic Medicine. 22(8). 1031–1036. 29 indexed citations

14.

Thomason, Margaret J., Helen M. Colhoun, Shona Livingstone, et al.. (2004). Baseline characteristics in the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with Type 2 diabetes. Diabetic Medicine. 21(8). 901–905. 15 indexed citations

15.

Colhoun, Helen M., D. J. Betteridge, Paul N. Durrington, et al.. (2004). Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. The Lancet. 364(9435). 685–696. 2724 indexed citations breakdown →

16.

Colhoun, Helen M., Margaret J. Thomason, Mike Mackness, et al.. (2002). Design of the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with Type 2 diabetes. Diabetic Medicine. 19(3). 201–211. 77 indexed citations

17.

Thomason, Margaret J.. (2000). Which spirometric indices best predict subsequent death from chronic obstructive pulmonary disease?. Thorax. 55(9). 785–788. 42 indexed citations

18.

Thomason, Margaret J., Joanne Lord, Murray Bain, et al.. (1998). A systematic review of evidence for the appropriateness of neonatal screening programmes for inborn errors of metabolism. Journal of Public Health. 20(3). 331–343. 46 indexed citations

19.

Shojaee‐Moradie, Fariba, A. Margot Umpleby, Margaret J. Thomason, et al.. (1995). A comparison of the effects of insulin‐like growth factor‐I, insulin and combined infusions of insulin and insulin‐like growth factor4 on glucose metabolism in dogs. European Journal of Clinical Investigation. 25(12). 920–928. 4 indexed citations

20.

Umpleby, A. Margot, Fariba Shojaee‐Moradie, Margaret J. Thomason, et al.. (1994). Effects of insulin‐like growth factor‐I (IGF‐I), insulin and combined IGF‐I‐insulin infusions on protein metabolism in dogs. European Journal of Clinical Investigation. 24(5). 337–344. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact